Loading clinical trials...
Loading clinical trials...
Investigating the Effects of Ethanol on Atrial Fibrillation Susceptibility and Pathogenesis
Conditions
Interventions
Ethanol
Placebo
Locations
1
United States
University of California, San Francisco
San Francisco, California, United States
Start Date
September 1, 2012
Primary Completion Date
May 1, 2019
Completion Date
May 1, 2020
Last Updated
March 16, 2021
NCT06676059
NCT05855668
NCT05147792
NCT02815891
NCT06935591
NCT07237750
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions